(Q53328060)

English

Efficacy of memantine in delaying clinical worsening in Alzheimer's disease (AD): responder analyses of nine clinical trials with patients with moderate to severe AD.

scientific article published on 25 August 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/22513699

Efficacy of memantine in delaying clinical worsening in Alzheimer's disease (AD): responder analyses of nine clinical trials with patients with moderate to severe AD. (English)

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/22513699

Alzheimer's disease

1 reference

based on heuristic

inferred from title

author name string

Rainer Hellweg

1

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/22513699

Yvonne Wirth

2

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/22513699

Wolfgang Janetzky

3

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/22513699

Susanne Hartmann

4

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/22513699

language of work or name

0 references

publication date

25 August 2011

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/22513699

International Journal of Geriatric Psychiatry

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/22513699

27

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/22513699

651-656

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/22513699

6

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/22513699

Outcome measures in clinical trials on medicinal products for the treatment of dementia: a European regulatory perspective

1 reference

https://api.crossref.org/works/10.1002%2FGPS.2766

21 January 2018

Key methodological features of randomized controlled trials of Alzheimer's disease therapy. Minimal clinically important difference, sample size and trial duration

1 reference

https://api.crossref.org/works/10.1002%2FGPS.2766

21 January 2018

A responder analysis of memantine treatment in patients with Alzheimer disease maintained on donepezil.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.2766

21 January 2018

A 24-week randomized, controlled trial of memantine in patients with moderate-to-severe Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.2766

21 January 2018

Activities of daily living in moderate-to-severe Alzheimer disease: an analysis of the treatment effects of memantine in patients receiving stable donepezil treatment.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.2766

21 January 2018

Alzheimer's disease in real life--the dementia carer's survey.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.2766

21 January 2018

Memantine in dementia: a review of the current evidence

1 reference

https://api.crossref.org/works/10.1002%2FGPS.2766

21 January 2018

Nursing home placement is related to dementia progression: experience from a clinical trial. Alzheimer's Disease Cooperative Study.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.2766

21 January 2018

Memantine treatment in mild to moderate Alzheimer disease: a 24-week randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.2766

21 January 2018

Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FGPS.2766

21 January 2018

Pharmacodynamics of memantine: an update

1 reference

https://api.crossref.org/works/10.1002%2FGPS.2766

21 January 2018

Memantine in moderate-to-severe Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FGPS.2766

21 January 2018

Treatment with cholinesterase inhibitors and memantine of patients in the Alzheimer's Disease Neuroimaging Initiative

1 reference

https://api.crossref.org/works/10.1002%2FGPS.2766

21 January 2018

Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FGPS.2766

21 January 2018

Analysis of the effect of memantine in reducing the worsening of clinical symptoms in patients with moderate to severe Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.2766

21 January 2018

Effectiveness of donepezil in reducing clinical worsening in patients with mild-to-moderate alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FGPS.2766

21 January 2018

Pharmacotherapy of Alzheimer's disease: is there a need to redefine treatment success?

1 reference

https://api.crossref.org/works/10.1002%2FGPS.2766

21 January 2018

Memantine in moderate to severe Alzheimer's disease: a meta-analysis of randomised clinical trials.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.2766

21 January 2018

Patient and caregiver characteristics and nursing home placement in patients with dementia

1 reference

https://api.crossref.org/works/10.1002%2FGPS.2766

21 January 2018

Memantine treatment in patients with mild to moderate Alzheimer's disease: results of a randomised, double-blind, placebo-controlled 6-month study.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.2766

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical practice. Early Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FGPS.2766

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/GPS.2766

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/22513699

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/22513699

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53328060&oldid=1503586759"